Table 4.
Baseline characteristics of participants.
| Control (n=58) |
Hypertension (n=53) |
+ARB (n=71) |
|
|---|---|---|---|
| Age, yrs | 59.28±1.47 | 60.83±1.43 | 61.48±1.32 |
| Male (% of total) | 29(15.9%) | 27(14.8%) | 34(18.7%) |
| Female (% of total) | 29(15.9%) | 26(14.3%) | 37(20.7%) |
| SBP(mmHg) | 124.36±2.48 | 146.42±2.78** | 137.35±1.98## |
| DBP(mmHg) | 74.24±1.35 | 82.04±1.51** | 75.54±1.32## |
| FBG, mmol/L | 5.49±0.07 | 5.53±0.08 | 5.50±0.08 |
| TG, mmol/L | 1.46±0.08 | 1.50±0.80 | 1.56±0.08 |
| TC, mmol/L | 5.14±0.11 | 5.31±0.10 | 5.33±0.08 |
| HDL, mmol/L | 1.38±0.04 | 1.27±0.05 | 1.35±0.05 |
| LDL, mmol/L | 3.09±0.12 | 2.64±0.11 | 2.84±0.29 |
| ALT, U/L | 26.02±1.55 | 26.35±2.48 | 26.99±2.38 |
| AST, U/L | 22.50±1.02 | 22.99±1.11 | 23.60±1.17 |
| BUN, mmol/L | 5.24±0.17 | 5.29±0.21 | 5.62±0.14 |
| UA, mmol/L | 348.97±11.53 | 349.92±12.90 | 355.41±11.26 |
| Cr, μmol/L | 84.07±1.22 | 85.19±1.07 | 85.75±0.81 |
Data presented as mean ± SEM.
**
P lt;0.01 vs. control,
##
P <0.01 vs. hypertension. Abbreviations: Control for the healthy control people (n=58); hypertension for the essential hypertensive patients without any drugs(n=53); +ARB, the essential hypertensive patients only with angiotensin II receptor blockage for treatment(n=71); SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, Triglyceride; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; ALT, Alanine transaminase; AST, Aspartate transaminase; BUN, blood urea nitrogen; UA, uric acid; Cr, creatinine.